321 related articles for article (PubMed ID: 20642837)
1. Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.
Alexopoulou AN; Leao M; Caballero OL; Da Silva L; Reid L; Lakhani SR; Simpson AJ; Marshall JF; Neville AM; Jat PS
Breast Cancer Res; 2010; 12(4):R51. PubMed ID: 20642837
[TBL] [Abstract][Full Text] [Related]
2. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
3. BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation.
Anderson LR; Sutherland RL; Butt AJ
Oncogene; 2010 Jan; 29(4):527-38. PubMed ID: 19881545
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy.
Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
Endocr Relat Cancer; 2015 Oct; 22(5):831-40. PubMed ID: 26229035
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
7. Fluid flow exposure promotes epithelial-to-mesenchymal transition and adhesion of breast cancer cells to endothelial cells.
Fuh KF; Shepherd RD; Withell JS; Kooistra BK; Rinker KD
Breast Cancer Res; 2021 Oct; 23(1):97. PubMed ID: 34641959
[TBL] [Abstract][Full Text] [Related]
8. Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells.
Li P; Tian W; Ma X
Mol Cancer; 2014 Jun; 13():138. PubMed ID: 24894151
[TBL] [Abstract][Full Text] [Related]
9. Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes.
Benzina S; Beauregard AP; Guerrette R; Jean S; Faye MD; Laflamme M; Maïcas E; Crapoulet N; Ouellette RJ; Robichaud GA
Oncotarget; 2017 Feb; 8(7):12052-12066. PubMed ID: 28076843
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
Cai D; Cao J; Li Z; Zheng X; Yao Y; Li W; Yuan Z
BMC Cancer; 2009 Apr; 9():102. PubMed ID: 19338666
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
12. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway.
Chen PS; Wang MY; Wu SN; Su JL; Hong CC; Chuang SE; Chen MW; Hua KT; Wu YL; Cha ST; Babu MS; Chen CN; Lee PH; Chang KJ; Kuo ML
J Cell Sci; 2007 Jun; 120(Pt 12):2053-65. PubMed ID: 17550972
[TBL] [Abstract][Full Text] [Related]
13. Transforming Growth Factor β/NR4A1-Inducible Breast Cancer Cell Migration and Epithelial-to-Mesenchymal Transition Is p38α (Mitogen-Activated Protein Kinase 14) Dependent.
Hedrick E; Safe S
Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28674186
[TBL] [Abstract][Full Text] [Related]
14. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
[TBL] [Abstract][Full Text] [Related]
15. Arachidonic acid induces an increase of β-1,4-galactosyltransferase I expression in MDA-MB-231 breast cancer cells.
Villegas-Comonfort S; Serna-Marquez N; Galindo-Hernandez O; Navarro-Tito N; Salazar EP
J Cell Biochem; 2012 Nov; 113(11):3330-41. PubMed ID: 22644815
[TBL] [Abstract][Full Text] [Related]
16. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
17. TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.
Seksenyan A; Kadavallore A; Walts AE; de la Torre B; Berel D; Strom SP; Aliahmad P; Funari VA; Kaye J
BMC Cancer; 2015 Jan; 15():22. PubMed ID: 25632947
[TBL] [Abstract][Full Text] [Related]
18. Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.
Hedrick E; Li X; Cheng Y; Lacey A; Mohankumar K; Zarei M; Safe S
Breast Cancer Res Treat; 2019 Aug; 177(1):29-40. PubMed ID: 31119568
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of the tumor-suppressive function of nischarin in breast cancer.
Baranwal S; Wang Y; Rathinam R; Lee J; Jin L; McGoey R; Pylayeva Y; Giancotti F; Blobe GC; Alahari SK
J Natl Cancer Inst; 2011 Oct; 103(20):1513-28. PubMed ID: 21917605
[TBL] [Abstract][Full Text] [Related]
20. Mechanotransduction of mitochondrial AMPK and its distinct role in flow-induced breast cancer cell migration.
Steele HE; Guo Y; Li BY; Na S
Biochem Biophys Res Commun; 2019 Jun; 514(2):524-529. PubMed ID: 31060777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
